New Insights Rifamycin B Biosynthesis : Isolation of Proansamycin B and 34a-Deoxy-rifamycin W as Early Macrocyclic Intermediates Indicating Two Separated Biosynthetic Pathways
-
- STRATMANN Ansgar
- Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
-
- SCHUPP Thomas
- Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
-
- TOUPET Christiane
- Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
-
- SCHILLING Wolfgang
- Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
-
- OBERER Lukas
- Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
-
- TRABER Rene
- Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
Search this article
Journal
-
- J. Antibiot.
-
J. Antibiot. 55 (4), 396-406, 2002-04-25
- Tweet
Details 詳細情報について
-
- CRID
- 1570572699688528512
-
- NII Article ID
- 10008472526
-
- NII Book ID
- AA0069330X
-
- ISSN
- 00218820
-
- Text Lang
- en
-
- Data Source
-
- CiNii Articles